A Clinical Study of 7 Cases of Ovarian Dysgerminoma.
- Author:
Jin Ho CHOI
1
;
Jung Yoon PARK
;
Il Soo PARK
Author Information
1. Department of Obstetrics and Gynecology, Kyungpook National University Hospital Daegu, Korea.
- Publication Type:Original Article
- Keywords:
Ovary;
Dysgerminoma
- MeSH:
Classification;
Drug Therapy;
Dysgerminoma*;
Female;
Gynecology;
Humans;
Incidence;
Lymph Nodes;
Neoplasm Metastasis;
Neoplasms, Germ Cell and Embryonal;
Obstetrics;
Ovary;
Prognosis
- From:Korean Journal of Gynecologic Oncology and Colposcopy
2001;12(4):325-330
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: To evaluate a clinical outcome of 7 patients diagnosed as ovarian dysgerminoma at the Department of Obstetrics and Gynecology, Kyunpookpook National University Hospital between 1994 and 1998 for 5 years. METHODS: After review of charts in seven patients, datas including clinical findings, treatment and outcome were analysed. RESULTS: The mean age of the patients with the ovarian dysgerminoma was 22 years and the highest incidence was shown in 10-19 years group. Among 7 patients, 5 cases(71.4%) were nulligravida, 2 cases of multigravida. According to FIGO classification, there were 5 cases of stage I(71.4%), 1 case(14.3%) of stage II and 1 case( 14.3%) of stage III. The clinical symptoms were abdominal distension(4 cases; 57.1%), palpable mass(4 cases; 57.1%), abdominal discomfort or pain(2 cases; 28.6%), amenorrhea(2 cases; 28.6%) and dysuria(1 case; 14.3%). Metastasis to other organ was found in 2 cases including pelvic cavity and paraaortic lymph node. Radiation therapy was performed on 1 case and chemotherapy on 4 cases after surgery. CONCLUSION: Dysgerminoma is the most common & radiosensitive malignant germ cell tumor of the ovary tumor. Dysgerminoma occurs usually between the ages of 10 and 30 years and has a relative better prognosis with postoperative chemotherapy than other malignant germ cell tumors.
